Secukinumab as new therapeuthic concept in Lupus Nephritis
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Systemic Lupus Erythematosus - A Phase II Clinical Trial
Lupus Nephritis - A Phase II Clinical Trial
Secukinumab as new therapeuthic concept in Lupus Nephritis
